These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 14083462)
21. Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone. Br Med J; 1978 Jun; 1(6125):1466-7. PubMed ID: 306273 [No Abstract] [Full Text] [Related]
22. Pyrazolidines in the treatment of gout. Kuzell WC Can Med Assoc J; 1968 Nov; 99(21):1038-43. PubMed ID: 5721943 [No Abstract] [Full Text] [Related]
24. [NEPHROPATHIES AND RENAL LITHIASIS IN GOUT PATIENTS (OLD AND NEW PROBLEMS)]. FOGLIERINI J Rhumatologie; 1963; 15():111-22. PubMed ID: 14186441 [No Abstract] [Full Text] [Related]
25. GOUT IN THE ELDERLY. MODERN MANAGEMENT IN HISTORICAL PERSPECTIVE. MCCORMICK EW Geriatrics; 1965 Sep; 20():756-8. PubMed ID: 14333673 [No Abstract] [Full Text] [Related]
35. BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO. BOSTROEM H; BERNTSEN K; WHITEHOUSE MW Biochem Pharmacol; 1964 Mar; 13():413-20. PubMed ID: 14157603 [No Abstract] [Full Text] [Related]
36. [CASE OF CHRONIC TOPHOCEOUS GOUT]. ITO H; OKAZAKI M; AKAOKA I; KOYAMA S Iryo; 1963 Dec; 17():736-40. PubMed ID: 14123823 [No Abstract] [Full Text] [Related]
37. Uricosuric drugs, with special reference to probenecid and sulfinpyrazone. Gutman AB Adv Pharmacol (1962); 1966; 4():91-142. PubMed ID: 5333771 [No Abstract] [Full Text] [Related]
38. [Gout from the view of a special hospital for rheumatic patients]. Klotz H; Prohaska E; Salmhofer H; Schmid L Wien Klin Wochenschr; 1971 Mar; 83(11):177-80. PubMed ID: 5314855 [No Abstract] [Full Text] [Related]
39. [The treatment of osteoarticular gout. (Reflections apropos of 230 personal cases)]. SERRE H; SIMON L Rhumatologie; 1962; 14():115-20. PubMed ID: 13988144 [No Abstract] [Full Text] [Related]